GPC3 and hepatocellular carcinoma: Therefore, two different Phase I trials using autologous second generation 41BBζ GPC3 CAR-T in adults with advanced HCC were performed [NCT 02395250; NCT03146234], and those studies are included in the 22 clinical trials investigating the use of CAR-T for HCC treatment.